Skip to Main Content

Paper Details

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Arthritis Res Ther
20
2019
-1 antitrypsin, CERS5, ETV7, IFN, ITGB1, IgG, KRT7, Ro52, Ro60, SLC13A3, SLE, SSA, SSA/SSB, SSB, SSB antibodies, Sjgren's syndrome, TYK2, aPL, aPL+, antiphospholipid syndrome, fibrinogen, immunoglobulin G, integrin beta-1, interferon, lupus, lupus anticoagulant, neutrophils, patients, plasma, rheumatoid factor, systemic lupus erythematosus, triglycerides
Author NameAffiliation
Iva GunnarssonKarolinska Institutet, Karolinska University Hospital
Janne Lehti??Clinical Proteomics Mass Spectrometry, Science for Life Laboratory and Karolinska Institutet
Peter NilssonKTH Royal Institute of Technology
Elisabet SvenungssonKarolinska Institutet, Karolinska University Hospital
  • 1 - 4

Datasets

Release 1.2